BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 3521114)

  • 1. [Etiology of acrodermatitis chronica atrophicans and erythema chronicum migrans].
    Herrmann WP
    Z Hautkr; 1986 Apr; 61(8):515-21. PubMed ID: 3521114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ixodes ricinus spirochete and European erythema chronicum migrans disease.
    Ackermann R; Kabatzki J; Boisten HP; Steere AC; Grodzicki RL; Hartung S; Runne U
    Yale J Biol Med; 1984; 57(4):573-80. PubMed ID: 6393609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer.
    Asbrink E; Hovmark A; Hederstedt B
    Acta Derm Venereol; 1984; 64(6):506-12. PubMed ID: 6084922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiology of erythema migrans disease and Lyme disease. Review and results of personal study].
    Neubert U
    Hautarzt; 1984 Nov; 35(11):563-70. PubMed ID: 6519987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays.
    Asbrink E; Hovmark A; Hederstedt B
    Acta Derm Venereol; 1985; 65(6):509-14. PubMed ID: 2420115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes.
    Asbrink E
    Acta Derm Venereol Suppl (Stockh); 1985; 118():1-63. PubMed ID: 3901647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans.
    Asbrink E; Hovmark A
    Acta Pathol Microbiol Immunol Scand B; 1985 Apr; 93(2):161-3. PubMed ID: 4013743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiological findings in erythema (chronicum) migrans and related disorders.
    Neubert U; Krampitz HE; Engl H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):237-52. PubMed ID: 3577483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans.
    Hulshof MM; Vandenbroucke JP; Nohlmans LM; Spanjaard L; Bavinck JN; Dijkmans BA
    Arch Dermatol; 1997 Jan; 133(1):33-7. PubMed ID: 9006370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrodermatitis chronica atrophicans, erythema chronicum migrans and lymphadenosis benigna cutis--spirochetal diseases?
    Frithz A; Lagerholm B
    Acta Derm Venereol; 1983; 63(5):432-6. PubMed ID: 6197845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acrodermatitis chronica atrophicans].
    Wittmann D; Heppt M; Ruzicka T
    MMW Fortschr Med; 2016 Mar; 158(6):64, 66-7. PubMed ID: 27084166
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental Lyme disease in rabbits: spirochetes found in erythema migrans and blood.
    Kornblatt AN; Steere AC; Brownstein DG
    Infect Immun; 1984 Oct; 46(1):220-3. PubMed ID: 6480108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological diagnosis of erythema migrans disease and related disorders.
    Wilske B; Schierz G; Preac-Mursic V; Weber K; Pfister HW; Einhäupl K
    Infection; 1984; 12(5):331-7. PubMed ID: 6392104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spirochete etiology of erythema chronicum migrans disease].
    Ackermann R; Kabatzki J; Boisten HP; Steere AC; Grodzicki RL; Hartung S; Runne U
    Dtsch Med Wochenschr; 1984 Jan; 109(3):92-7. PubMed ID: 6363033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The spirochetal etiology of erythema chronicum migrans and of meningo-polyneuritis Garin-Bujadoux-Bannwarth].
    Ackermann R
    Z Hautkr; 1983 Nov; 58(22):1616, 1619-21. PubMed ID: 6659638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma.
    Müllegger RR; Means TK; Shin JJ; Lee M; Jones KL; Glickstein LJ; Luster AD; Steere AC
    Infect Immun; 2007 Sep; 75(9):4621-8. PubMed ID: 17606602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of spirochetes from the skin of patients with erythema chronicum migrans in Austria.
    Stanek G; Wewalka G; Groh V; Neumann R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Aug; 260(1):88-90. PubMed ID: 4060924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis.
    Picken MM; Picken RN; Han D; Cheng Y; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Strle F
    Mol Pathol; 1997 Aug; 50(4):186-93. PubMed ID: 9350301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin manifestations of Lyme borreliosis].
    Nammous AH; Zubacki D; Dobrzycki I
    Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.